← back to search

Rebecca Legarth

Statens Serum Institut · DK
Area of research
Infectious Diseases · Emergency Medicine
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and HIV/AIDS Research and Interventions.
h-index
17
citations
1,224
works
29
NIH funding
primary concept
Medicine
email

Recent publications

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
PLoS Medicine 2022cited by 154position: middledoi
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
The Lancet Infectious Diseases 2022cited by 105position: middledoi
Observed protection against SARS-CoV-2 reinfection following a primary infection: A Danish cohort study among unvaccinated using two years of nationwide PCR-test data
The Lancet Regional Health - Europe 2022cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian Holm Hansen · Statens Serum Institut3 papers (2022–2022)Steen Ethelberg · Statens Serum Institut3 papers (2022–2022)Palle Valentiner‐Branth · Statens Serum Institut3 papers (2022–2022)Mie Agermose Gram · Statens Serum Institut2 papers (2022–2022)Peter Bager · Statens Serum Institut2 papers (2022–2022)Jannik Fonager · Statens Serum Institut2 papers (2022–2022)Nikolaj Ulrik Friis · Statens Serum Institut2 papers (2022–2022)Marc Stegger · Statens Serum Institut2 papers (2022–2022)Camilla Holten Møller · Copenhagen University Hospital1 papers (2022–2022)Morten Rasmussen · University of Hong Kong1 papers (2022–2022) · 1 papers (2022–2022)Tyra Grove Krause · Statens Serum Institut1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Niels Obel · University Hospital Frankfurt1 papers (2022–2022)Anders Fomsgaard · Statens Serum Institut1 papers (2022–2022)Sophie Gubbels · Statens Serum Institut1 papers (2022–2022) · 1 papers (2022–2022)Daniela Michlmayr · European Centre for Disease Prevention and Control1 papers (2022–2022)